Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hims vs Medro

Hims and Medro both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Hims logo

Hims

6.8
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC

Visit Hims →
VS
Medro logo

Medro

6.7
★★★☆☆3.4/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Medro →

If you are choosing between Hims and Medro, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hims leads our six-part score, 6.8 to 6.7. One of the two has an FDA warning letter on record, covered below.

Hims vs Medro price

Hims and Medro start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Hims prices compounded injections and brand-name pens, while Medro prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.

Where each one treats patients

Hims lists 50 states, and Medro lists 50 states.

They overlap in 50 states.

Pricing

Hims

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)

Medro

MonthlyCompounded
$199/mo
semaglutide

Month-to-month; drops to $179/mo (3-month), $159/mo (6-month), or $149/mo (12-month). Illustrative — final price shown before checkout, may vary by dose/pharmacy/eligibility.

MonthlyCompounded
$299/mo
tirzepatide

Month-to-month; drops to $269/mo (3-month), $239/mo (6-month), or $224/mo (12-month). Illustrative — final price shown before checkout. Brand-name GLP-1 options also available if eligible.

What each price covers

Both prices cover the medication itself.

Medro's price also covers shipping, which Hims does not claim.

Hims is silent on shipping and lab work.

Medro is silent on the clinician visit, lab work and coaching.

Hims

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Medro

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Hims scores 6.8 and Medro 6.7 out of 10.

Hims is stronger on user experience (8.0 vs 5.0) and trust & safety (7.0 vs 6.0).

Medro is stronger on value (4.5 vs 3.0) and support (4.5 vs 3.0).

Effectiveness and accessibility are within half a point.

How we score

Hims

6.8/10

Overall

Medro

6.7/10

Value25%

3.0A
vs
B
4.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
5.0

Trust & Safety15%

7.0A
vs
B
6.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
4.5

FDA warning letters

The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.

Medro has no FDA warning letter on record with us.

Features & Coverage

FeatureHimsMedro
Starting Price$199/mo$199/mo
Features2 features✓8 features
States Available5050
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Hims

Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.

Read our full Hims review →

About Medro

Pricing is tiered by commitment and shown before checkout: semaglutide $149-$199/mo and tirzepatide $224-$299/mo, with free shipping and no membership. The final price can still vary by dose, pharmacy and eligibility. Medro Health Technologies, Inc. sells compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, through a partner medical group and licensed pharmacy partners in all 50 states. An online intake goes to a licensed provider who decides if treatment fits. LegitScript-certified.

Read our full Medro review →

Pros & Cons

Hims

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Medro

What we like

  • Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • The monthly price includes the medication and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Medro

Watch-outs

  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hims

Hims wins this one, 6.8 to 6.7, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Medro fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Hims if…

You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.

Choose Medro if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

6.1

DudeMeds

Compounded semaglutide at $175/month

Hims vs Medro: FAQ

Neither on the entry price: Hims and Medro both start at about $199 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Both list 50 states and share 50.
Both include the medication itself. Only Medro includes shipping.
Hims has an open FDA warning letter from September 9, 2025. Medro has none.
No. Neither Hims nor Medro pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.